Clustering analysis for predicting racial disparities in genitourinary cancer–related financial burden.

Yanjia Zhang,Atulya Aman Khosla,Sufal Chhabra,Nitya Batra,Mohammad Arfat Ganiyani,Anmol Goyal,Shreyas S Bellur,Rohit Singh,Karan Jatwani,Venkataraghavan Ramamoorthy,Muni Rubens,Anshul Saxena,Rohan Garje
DOI: https://doi.org/10.1200/jco.2024.42.16_suppl.e13612
IF: 45.3
2024-05-31
Journal of Clinical Oncology
Abstract:e13612 Background: Healthcare costs in the United States (US) are significantly impacted by genitourinary (GU) cancers. Prostate cancer treatment alone cost the US more than 17974 (13816, 22133), 30512 (21389, 39635), respectively. Regression analysis showed that, after adjusting for sampling weight, cluster, gender, family income, age, insurance status, and survey year, the mean total expenditure was higher by 13100.81 in med- and high-risk clusters when compared to the low-risk cluster (ref.). Within each race or ethnicity, the proportion of Hisp or NHB individuals was higher in med- and high-risk clusters. Med- and high-risk clusters were more likely to contain people with cognitive impairments, poor health status, and financial difficulties in their families. Conclusions: We used an unsupervised clustering algorithm that can distinguish between GU cases with high and low expenditure based solely on sociodemographic variables. We demonstrate that our findings were consistent for all three data cohorts. This approach can predict the disparity in utilization in any insured population. [Table: see text]
oncology
What problem does this paper attempt to address?